CNE100003RT3
CNE100003RT3
XIAMEN AMOYTOP BIOTECH CO LTD
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 20.72B EUR | 22.21B EUR | 26.45B EUR | 34.16B EUR |
Enterprise Value | 20B EUR | 22.14B EUR | 25.7B EUR | 33.78B EUR |
Valuation Multiples | ||||
Trailing P/E | 19.3x | 26.38x | 34.11x | 43.07x |
Forward P/E | 14.85x | -- | -- | -- |
Price to Sales | 5.15x | 7.27x | 9.28x | 12.53x |
Price to Book | 6.5x | 7.15x | 7.29x | 9.9x |
EV/Revenue | 4.97x | 7.25x | 9.01x | 12.39x |
EV/EBITDA | 14.04x | 22.74x | 28.92x | 36.77x |
Price to FCF (P/FCF) | 72.91x | 61.27x | 76.65x | 78.95x |
EV/FCF | 70.36x | 61.08x | 74.47x | 78.08x |
FCF Yield | 1.37% | 1.63% | 1.3% | 1.27% |